{
    "code": "02025472",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02025472",
    "time": "2022-06-10 03:52:28",
    "許可證字號": "衛署藥輸字第025472號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "111\/06\/30",
    "發證日期": "100\/07\/25",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "第一等級醫療器材原登錄字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHA00202547206",
    "中文品名": "宜保安濃縮輸注液1毫克\/毫升",
    "英文品名": "Evoltra concentrate for solution for infusion",
    "適應症": "至少使用過兩種常用投藥法治療無效，且已可預見無其他療法能達到持久反應之復發(Relapsed)或難治(Refractory)的1~21歲急性淋巴母細胞白血病(Acute Lymphoblastic Leukemia)病人。",
    "劑型": "",
    "包裝": "20mg\/20ml小瓶 100小瓶以下盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "CLOFARABINE",
    "限制項目": "02輸　入",
    "申請商名稱": "1424601100  賽諾菲股份有限公司",
    "申請商地址": "台北市信義區松仁路3號7樓",
    "主製造廠": [
        {
            "製造廠名稱": "FNL0029100  PHARMACHEMIE B.V.",
            "製造廠廠址": "SWENSWEG 5, GA HAARLEM,THE NETHERLANDS",
            "製造廠公司地址": "",
            "製造廠國別": "NETHERLANDS",
            "製程": ""
        }
    ],
    "次製造廠": [
        {
            "製造廠名稱": "7770824858  台灣大昌華嘉股份有限公司",
            "製造廠廠址": "桃園市楊梅區梅獅路二段629號",
            "製造廠公司地址": "",
            "製造廠國別": "TAIWAN",
            "製程": "二級包裝廠(委託貼標及置入仿單)"
        },
        {
            "製造廠名稱": "FGB0200000  GENZYME LIMITED",
            "製造廠廠址": "37 HOLLANDS ROAD; HAVERHILL; SUFFOLK; CB9 8PU UK",
            "製造廠公司地址": "",
            "製造廠國別": "UNITED KINGDOM",
            "製程": "包裝"
        }
    ],
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1012002000",
            "成分名稱": "CLOFARABINE",
            "含量描述": "",
            "含量": "1.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "Evoltra_TWPI_CN_CCDS v09_in use-110-12-16(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025472&Seq=009&Type=9"
        },
        {
            "title": "Evoltra_LPI_C_CCDS v09_approval-108-11-04(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025472&Seq=008&Type=9"
        },
        {
            "title": "Evoltra_LPI_E_CCDS v09_approval-105-08-15.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025472&Seq=007&Type=9"
        },
        {
            "title": "020254720001___20110817.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025472&Seq=001&Type=8"
        }
    ]
}